Synopsys (SNPS, Financials) said the UK Competition and Markets Authority has provisionally approved its suggested remedies on the company's intended $35 billion purchase of Ansys. The ruling keeps the transaction from moving on to a Phase 2 inquiry, therefore opening the path for the expected closing of the merger in the first half of 2025.

Synopsys said in a statement that they approved of the CMA's choice as the combination will provide great customer service. As the clearance process goes on, the business stated it would maintain positive and cooperative engagement with authorities. Subject to all necessary regulatory permissions, Synopsys expects the acquisition to conclude in the first half of 2025.

Critical for improving system design across many sectors, the purchase is positioned to meet growing market demand for integrated electronic design automation and Simulation and Analysis software. Combining their own skills will help Synopsys and Ansys boost innovation by simplifying client research and development initiatives.

Originally established in California, Synopsys offers system verification, silicon-to-system design solutions comprising electronic design automation tools, silicon IP, and system validation. Products from the firm satisfy semiconductor and systems needs of different sectors. Offering engineering product development solutions, Ansys specializes in simulation tools.

Concerns about market competitiveness have drawn attention to the merger; officials are assessing the possible impact of the agreement. Synopsys reaffirmed its commitment to handling regulatory issues and voiced confidence in the approach.

The adoption of the company's suggested remedies by regulators signals a major turning point for the acquisition, which is supposed to change the competitive environment in semiconductor design and simulation technologies.